Sophie G. Carlson

Hematology Oncology | Hematology | Oncology

200 Ucla Medical Plz
Suite 165 34
Los Angeles, CA 90095

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 5 publications

Impact of clonal hematopoiesis of indeterminate potential on treatment outcomes in multiple myeloma patients undergoing CAR-T cell therapy.

Impact of clonal hematopoiesis of indeterminate potential on treatment outcomes in multiple myeloma patients undergoing CAR-T cell therapy.

Journal: International journal of hematology

Published: April 14, 2026

Allogeneic chimeric antigen receptors (CARs) as an "off-the-shelf" therapy in multiple myeloma.

Allogeneic chimeric antigen receptors (CARs) as an "off-the-shelf" therapy in multiple myeloma.

Journal: Immunotherapy

Published: February 17, 2025

The Impact of Social Determinants of Health on Peripheral T Cell Lymphoma Outcomes: Treatment Center-Type Emerges as a Powerful Prognostic Indicator.

The Impact of Social Determinants of Health on Peripheral T Cell Lymphoma Outcomes: Treatment Center-Type Emerges as a Powerful Prognostic Indicator.

Journal: Clinical lymphoma, myeloma & leukemia

Published: July 31, 2024

Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions.

Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions.

Journal: Blood advances

Published: February 17, 2023

Radiation therapy in the management of unilesional primary cutaneous T-cell lymphomas.

Radiation therapy in the management of unilesional primary cutaneous T-cell lymphomas.

Journal: The British journal of dermatology

Published: November 09, 2011

Showing 1-5 of 5

Last Updated: 09/26/2026